Posts Tagged: breast oncology

Standard-of-Care Treatment Approaches for HR+/HER2 Early Breast Cancer ft. Dr. Gregory Vidal

Posted by & filed under Uncategorized.

In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer.   Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »

Breast Cancer

Posted by & filed under Uncategorized.

1 in 8 women in the US will develop breast cancer in their lifetime, but regular screening dramatically increases the odds of recovery. Breast cancer is a very complex disease, and each case is unique. At West Cancer Center & Research Institute our team of specialist understands that no two breast cancer cases are alike.... Read more »

Meet Dr. Michael Berry

Posted by & filed under Uncategorized.

MEET DR. MICHAEL BERRY, Director of our Margaret West Comprehensive Breast Center To know him is to absolutely love him! He is a personable, knowledgable, and compassionate breast surgeon practicing at our Germantown campus. Margaret West Comprehensive Breast Center offers a full suite of breast health services to women from annual mammograms to on-site biopsies, MRIs, ultrasounds,… Read more »

Dr. Lee Schwartzberg on HER2– HR+ Breast Cancer: Tesetaxel & Capecitabine

Posted by & filed under Uncategorized.

Lee S. Schwartzberg, MD, of the West Cancer Center, discusses phase III results from the CONTESSA study, which showed that an all-oral regimen of tesetaxel plus a reduced dose of capecitabine significantly improved progression-free survival compared with capecitabine alone in patients with HER2-negative, hormone receptor–positive metastatic breast cancer previously treated with a taxane (Abstract GS4-01)…. Read more »